Overview

Gender

male

Investor Type

Investment Partner,Angel

Steven D. Weinstein is a Managing Director in Cambridge, MA, USA.

Steve focuses on both medical device and bio/pharma investments for the fund. He brings significant operating and venture capital experience to Novartis' investing efforts. Steve joined the Novartis Venture Fund in 2006 as a Managing Director. He has led the investments and serves on the board of Ablation Frontiers (acquired by Medtronic), Autonomic Technologies, Portaero, Sonitus Medical, and Visiogen (acquired by Abbott).



Prior to Novartis, Steve was at Prism Venture Partners, where he focused on medical devices and served on the boards of iScience Interventional, ROX Medical, and Sensitech (acquired by Carrier/UTX). Prior to Prism, Steve was a Principal and Kauffman Fellow with the Mid-Atlantic Venture Funds. He started his career as an entrepreneur and CEO, raising angel funds to buy the assets of a defunct distribution business out of bankruptcy, and then rebuilt the business over the next several years.

Steve holds an MBA with distinction from the University of Michigan Business School and a BS in mechanical engineering from Columbia University's School of Engineering and Applied Science. He serves on the University of Michigan Wolverine Venture Fund Advisory Board and on the board of the Family to Family project.